Candriam SCA’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Candriam SCA’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-604,379	Closed	-$5.91M	–	854
2021 Q4	$5.91M	Sell	604,379 -103,738	-15%	-$1.95M	0.04%	327
2021 Q3	$24.1M	Hold	708,117	–	–	0.16%	145
2021 Q2	$25.9M	Buy	708,117 +531,462	+301%	+$20.6M	0.18%	139
2021 Q1	$9.68M	Buy	176,655 +19	+0%	+$885	0.08%	252
2020 Q4	$10.1M	Sell	176,636 -72,883	-29%	-$4.32M	0.08%	257
2020 Q3	$12.8M	Sell	249,519 -2,196	-0.9%	-$108K	0.12%	189
2020 Q2	$15M	Buy	251,715 +251,701	+1,797,864%	+$13.5M	0.16%	159
2020 Q1	$1K	Buy	+14	New	+$777	﹤0.01%	791

Other funds holding DCPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Candriam SCA's DCPH Position: Q1 2022 in Review

Candriam SCA sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 604,379 shares — an estimated $5.91M sold.

Candriam SCA first reported a position in DCPH in Q1 2020 and held it in 8 quarters. The position peaked at $25.9M in Q2 2021. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

Candriam SCA reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Candriam SCA sold 604,379 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $5.91M.
Candriam SCA first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 8 quarters.
Candriam SCA's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $25.9M in Q2 2021.
123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Candriam SCA's 13F filing for Q1 2022, filed 13 May 2022.